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Abstract
Arrhythmias have been one of the common complications in epilepsy patients and have also
been the reason for death. However, limited data exist about the burden and outcomes of
arrhythmias by subtypes in epilepsy. Our study aims at evaluating the burden and differences in
outcomes of various subtypes of arrhythmias in epilepsy patient population. The Nationwide
Inpatient Sample (NIS) database from 2014 was examined for epilepsy and arrhythmias related
discharges using appropriate International Classification of Disease, Ninth Revision Clinical
Modification (ICD-9-CM) codes. The frequency of arrhythmias, gender differences in
arrhythmia by subtypes, in-hospital outcomes and mortality predictors was analyzed. A total of
1,424,320 weighted epilepsy patients was determined and included in this study. Around 23.9%
(n =277,230) patients had cardiac arrhythmias. The most frequent arrhythmias in the
descending frequency were: atrial fibrillation (AFib) 9.7%, other unspecified causes 7.3%,
sudden cardiac arrest (SCA) 1.4%, bundle branch block (BBB) 1.2%, ventricular tachycardia (VT)
1%. Males were more predisposed to cardiac arrhythmias compared to females (OR [odds ratio]:
1.1, p <0.001). The prevalence of most subtypes arrhythmias was higher in males. Arrhythmias
were present in nearly a quarter of patients with epilepsy. Life threatening arrhythmias were
more common in male patients. The length of stay (LOS) and mortality were significantly
higher in epilepsy patients with arrhythmia. It is imperative to develop early diagnosis and
prompt therapeutic measures to reduce this burden and poor outcomes due to concomitant
arrhythmias in epilepsy patients.
Categories: Cardiology, Emergency Medicine, Neurology
Keywords: in-hospital outcomes, epilepsy, seizures, sudep, arrhythmias, dysautonomia
Introduction
The heart and brain are two vital organs for life to be under control of an autonomic nervous
system and there is a coordination between them. Any pathological conditions involving one of
them might influence the other. We aimed at studying the presence of arrhythmia in epileptic
patients. In this study, we also analysed about the frequency and overall incidence of various
subtypes of arrhythmias including atrial fibrillation (AFib), atrial flutter (AFL), ventricular
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fibrillation (V-fib), ventricular flutter (VFL), sinoatrial (SA) dysfunction, atrioventricular (AV)
block, premature atrial complex (PAC), premature ventricular contractions (PVC), paroxysmal
supraventricular tachycardia (PSVT), bundle branch block (BBB), Wolff Parkinson White
syndrome (WPW) and sudden cardiac arrest (SCA). Autonomic dysfunction in epilepsy is one of
the causes of cardio respiratory abnormalities in patients suffering from epilepsy. Those
cardiorespiratory abnormalities might cause apnea, arrhythmia and sudden death in patients
[1-2].
 
Many authors believed that the cause of s udden unexpected death in epilepsy (SUDEP) is an
arrhythmia. Heart rate variability is defined as a marker for autonomic dysfunction, which can
eventually lead to sudden death from arrhythmia. Such phenomenon is also seen in Parkinson’s
disease and multiple system atrophy. Therefore, heart rate is also an important marker to
prevent serious cardiac morbidity in epilepsy. Such variations should not be neglected as it can
have hazardous consequences [3-4].
 
In epilepsy, 10-40% patients suffer intractable seizures, which might lead to sudden death due
to cardiorespiratory failure. This study signifies the importance of electrophysiological
monitoring in epilepsy patients. The arrhythmia occurs because of the disorder of bioelectrical
activity due to the molecular mechanism or as an adverse effect of treatment with antiepileptic
drugs (AED) itself. Therefore, an importance of the treatment induced arrhythmia in epilepsy
should be kept in mind. Many drugs like carbamazepine, levetiracetam, etc. are notorious for
causing cardiac arrhythmias in epilepsy patients [5-6]. 
Materials And Methods
Source of data
We utilized the discharge data from the National Inpatient Sample (NIS) of Healthcare Cost and
Utilization Project (HCUP). The NIS is the largest all-payers' data set for inpatient admissions
and discharges from almost 1050 United States of America hospitals [7]. It provides cross-
sectional data on almost eight million inpatient admissions and discharge data per year and
represents around 20% (hospitals from 45 states) stratified sample of all nonfederal hospitals.
Data for each hospital admission contains one primary discharge diagnosis and up to 29
secondary diagnoses. The NIS data set does not include long-term care and rehabilitation
facilities. The NIS data set is unweighted and it results in the weighted estimate of the total
discharge number of the US population when the discharge weight (DISCWT) is applied to the
unweighted data. We excluded the data of missing information such as age, gender, discharge
condition or primary diagnosis. The NIS is an all payer database of HCUP sponsored by Agency
for Healthcare Research and Quality (AHRQ), and it does not require an approval from
institutional review board (IRB) because the data set is de-identified. More details on the
dataset content and methods of collections are accessible on the HCUP website [7].
The Clinical Classifications Software (CCS) code 83 was used to identify the primary diagnosis
of epilepsy shown in Table 1. These codes are used to get the national estimates on various
variables in previous studies. Other demographic information that could potentially affect the
hospitalization outcomes like obesity, hypertension, diabetes, hyperlipidemia, sepsis,
pneumonia and end stage renal disease, etc. were identified using International Classification
of Disease, Ninth Edition, Clinical Modification (ICD-9-CM) codes (Table 1).
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Condition Source Codes
Atrial fibrillation (AF) ICD-9 427.31
Atrial flutter (Afl) ICD-9 427.32  
Wolff-Parkinson-White syndrome (WPW) ICD-9 426.7
Nonparoxysmal atrioventricular (AV) nodal
tachycardia ICD-9 426.89  
Paroxysmal supraventricular tachycardia (PSVT) ICD-9 427.0  
Paroxysmal ventricular tachycardia (VT) ICD-9 427.1
Ventricular premature beats ICD-9 427.69
Ventricular fibrillation (VF) ICD-9 427.41
Ventricular flutter (Vfl) ICD-9 427.42
Sudden Cardiac Arrest (SCA) ICD-9 427.5
Premature atrial/ventricular complexes (PAC/PVC) ICD-9 427.60, 427.61, 427.69
Sinoatrial (SA) node dysfunction ICD-9 427.81
Bundle branch block (BBB) ICD-9 426.2, 426.3, 426.4, 426.50, 426.51, 426.52, 426.53,426.54
Atrioventricular (AV) blocks ICD-9 426.0, 426.10, 426.11, 426.12, 426.13
Other, unspecified ICD-9 427.2, 427.9, 427.89, 785.0
Epilepsy CCS 83
TABLE 1: International Classification of Disease, Ninth Clinical Modification (ICD-9-
CM) and Clinical Classifications Software (CCS) codes used to identify subtypes of
arrhythmias and epilepsy.
Abbreviations: ICD-9= International Classification of Disease, Ninth Revision, CCS= Clinical Classifications Software.
Study outcomes and variables
We evaluated the frequency of various subtypes of arrhythmias in epilepsy patients. Subtypes
of arrhythmia were identified using ICD-9-CM codes shown in Table 1. In order to assess the
outcome of hospitalization owing to arrhythmias among epilepsy patient population, the length
of stay (LOS), in-hospital mortality and total charges were used.
Statistical analysis
We used the Statistical Package for the Social Science, version 22.0 from (IBM Corp., Armonk,
NY, USA) for all the statistical analysis. To generate the national estimate, we applied weights to
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unweighted records obtained from NIS. We compared demographics and comorbid risk factors
with arrhythmias and without arrhythmias in the patients hospitalized with the primary
diagnosis of epilepsy. Pearson’s chi-square test was used for categorical data and the
independent sample T-test was used for continuous data. Multivariable logistic regression was
used to assess the impact of arrhythmia by subtypes in epilepsy patients after adjusting for
variables significant in the univariate analysis. Standard weights provided by HCUP were
utilized to get the national weighted estimates of inpatient admissions and p <0.05 was defined
as the statistical significance.
Results
Baseline characteristics
After following rigorous inclusion and exclusion criteria and applying weights for unweighted
NIS data set, we could identify 1,424,320 inpatient admissions with the discharge diagnosis of
epilepsy in the year 2014. The comparison of baseline characteristics of epilepsy patients with
arrhythmias and without arrhythmias is presented in Table 2. Percentages of arrhythmias were
the highest (40.8%, p <0.001) in the age group of 65-84 years. Males (51.7% vs. 48.3%, p <0.001)
were more prone to have arrhythmias than females. Percentages of Caucasians were higher in
arrhythmia group (69.0% vs. 64.0%, p <0.001). Discharge to either skilled nursing facility or
intermediate care facility was higher in arrhythmia cohort (33.8% vs. 21.2%, p <0.001).
Variables No Arrhythmia Arrhythmia P-value*
Unweighted admissions 229418 55446  
Weighted admissions 1147090 277230  
Age in years at admission                                                                                
< 18 10.6% 4.1% <0.001
18 to 44 27.2% 12.7% <0.001
45 to 64 36.5% 28.6% <0.001
65 to 84 21.6% 40.8% <0.001
>85 4.1% 13.8 <0.001
Died during hospitalization                                                                             
Did not die 98.2% 91.1% <0.001
Died 1.8% 8.9% <0.001
Disposition of Patient                                                                                       
Routine 60.4% 37.7% <0.001
Transfer to short-term Hospital 2.6% 3.1% <0.001
Other Transfers (SNF, ICF) 21.2% 33.8% <0.001
Home Health Care 11.6% 15.2% <0.001
Against Medical Advice (AMA) 2.4% 1.3% <0.001
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Elective Vs. Non-elective Admissions                                                             
Non-elective 84.5% 90.9% <0.001
Elective 15.5% 9.1% <0.001
Indicator of Sex                                                                                                
Male 48.1% 51.7% <0.001
Female 51.9% 48.3% <0.001
Primary Expected Payer                                                                                 
Medicare 43.6% 64.5% <0.001
Medicaid 27.8% 15.8% <0.001
Private including HMO 20.6% 14.6% <0.001
Self - Pay 4.5% 2.8% <0.001
Race                                                                                                                   
Caucasian 64.0% 69.0% <0.001
Afro-American 20.6% 18.4% <0.001
Hispanic 10.1% 7.6% <0.001
Asian or Pacific Islander 1.4% 1.6% <0.001
Native American 0.7% 0.6% <0.001
Other 3.1% 2.8% <0.001
Bed Size of Hospital                                                                                        
Small 17.0% 16.9% <0.001
Medium 27.9% 28.9% <0.001
Large 55.1% 54.3% <0.001
Location/Teaching Status of Hospital                                                            
Rural 8.2% 7.8% <0.001
Urban - non teaching 23.2% 24.8% <0.001
Urban - teaching 68.6% 67.4% <0.001
TABLE 2: Baseline characteristics of hospitalized epilepsy patients without versus
with arrhythmia and epilepsy.
*Significant P-values ≤ 0.05 at 95% confidence Interval
Abbreviations: SNF- Skilled Nursing Facility, INF- Intermediate Nursing Facility, AMA- Against Medical Advice, HMO- Health
Maintenance Organization.
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Baseline comorbidities
Table 3 shows a comparison of different comorbidities between arrhythmia and no arrhythmia
cohorts. Comorbidities which are higher in non-arrhythmia cohort are depression (15.7% vs.
15.5%, p <0.001), psychosis  (12.1% vs. 9.7%, p<0.001) and alcohol abuse (8.5% vs. 7.2%, p
<0.001). While comorbidities that are higher in arrhythmia cohorts are congestive heart failure
(18.7% vs. 6.3%, p <0.001), valvular disorders (7.7% vs. 2.4%, p<0.001), paralysis (12.8% vs.
11.3%, p <0.001), coagulopathy (9.5% vs. 6.2%, p <0.001), diabetes (22.4% vs. 16%, p <0.001)
and fluid and electrolyte disorders (43.8% vs. 30%, p <0.001). Comparison of other
comorbidities is also shown in Table 3.
Variables No Arrhythmia Arrhythmia P-value*
Co –morbidities#
AIDS 0.5% 0.3% <0.001
Musculoskeletal
RA/CVD 2.8% 3.1% <0.001
Cardiovascular
Congestive Heart Failure 6.3% 18.7% <0.001
Valvular Disease 2.4% 7.7% <0.001
Peripheral Vascular Disorders 4.0% 8.4% <0.001
Respiratory
Chronic Pulmonary Disease 20.7% 25.5% <0.001
Pulmonary Circulation Disorders 1.5% 4.5% <0.001
Neurological
Paralysis 11.3% 12.8% <0.001
Other Neurological Disorders 67.9% 74.8% <0.001
Psychiatry
Depression 15.7% 15.5% 0.024
Psychoses 12.1% 9.7% <0.001
Alcohol Abuse 8.5% 7.2% <0.001
Hemato-oncological
Deficiency Anemia 17.5% 25.0% <0.001
Chronic Blood Loss Anemia 0.9% 1.1% <0.001
Coagulopathy 6.2% 9.5% <0.001
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Weight Loss 5.7% 8.7% <0.001
Metastatic Cancer 1.8% 2.0% <0.001
Solid Tumor without Metastasis 1.9% 2.2% <0.001
Lymphoma 0.5% 0.9% <0.001
Endocrinological
Diabetes, Uncomplicated 16.0% 22.4% <0.001
Hypothyroidism 12.1% 16.7% <0.001
Renal
Renal Failure 9.8% 18.7% <0.001
Fluid and Electrolyte Disorders 30.0% 43.8% <0.001
Gastrointestinal
Liver Disease 4.3% 4.1% <0.001
Obesity 9.2% 11.5% <0.001
TABLE 3: Co-morbidities of hospitalized epilepsy patients without versus with
arrhythmia.
*Significant P-values ≤ 0.05 at 95% confidence Interval, #Variables are Agency for Healthcare Research and Quality (AHRQ) co-
morbidity measures
Abbreviations: AIDS- acquired immunodeficiency syndrome, RA- rheumatoid arthritis, CVD- collagen vascular disease.
Spectrum and burden of arrhythmias
A total of 1,424,320 weighted epilepsy patients was included in the study and 23.9% (n
=277,230) of patients had cardiac arrhythmias. The most frequent arrhythmias in the
descending frequency were: atrial fibrillation (AFib) 9.7%, other unspecified causes 7.3%,
bundle branch block (BBB) 1.2%, ventricular tachycardia (VT) 1%, atrial flutter (AFL) 0.9%,
atrioventricular (AV) block 0.8% and sinoatrial (SA) node dysfunction 0.5%. Approximately
1.4% patients had sudden cardiac arrest during the hospitalization. Terminal point rhythm was
not available for such patients to further categorize the subtype. The burden of other subtypes
of arrhythmia in epilepsy patients is shown in detail in Figure 1. Many arrhythmia subtypes
have been associated with epilepsy patients [3, 8-9].
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FIGURE 1: Statistical representation of the percentage
distribution of arrhythmias by subtypes in the patients with
epilepsy.
AFib= atrial fibrillation, Afl= atrial flutter, PSVT= paroxysmal supraventricular tachycardia,
Vfib/Vfl= ventricular fibrillation/ventricular flutter, SCA= sudden cardiac arrest, PAC/PVC=
premature atrial complex/premature ventricular complex, SA= sinoatrial, BBB= bundle branch
block, AV= atrioventricular, WPW= Wolff-Parkinson-white.
Gender differences and in-hospital outcomes
We further analyzed gender differences in the arrhythmia distribution within epilepsy patients.
Males were more predisposed to cardiac arrhythmias compared to females (OR: 1.1, p <0.001).
Most subtypes of arrhythmias were higher in males (p <0.001). In contrast, paroxysmal
supraventricular tachycardia was comparatively higher in females (OR: 1.2, 1.08-1.23, p <0.001)
 (Figure 2).
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FIGURE 2: Statistical representation showing the gender
differences in arrhythmia distribution within epilepsy patients.
AFib= atrial fibrillation, Afl= atrial flutter, PSVT= paroxysmal supraventricular tachycardia,
Vfib/Vfl= ventricular fibrillation/ventricular flutter, SCA= sudden cardiac arrest, PAC/PVC=
premature atrial complex/premature ventricular complex, SA= sinoatrial, BBB= bundle branch
block, AV= atrioventricular, WPW= Wolff-Parkinson-white.
To evaluate the financial burden, we analyzed the in-hospital mortality, the length of stay
(LOS) and average total charge of hospitalization incurred due to arrhythmias in epilepsy
patients. The findings are shown in Table 4. Mortality rates owing to arrhythmias in epilepsy
patients were significantly higher (8.9% vs. 1.8%, p <0.001). The LOS beyond one week was
increased in arrhythmia group (p <0.001).
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Outcome Variables No Arrhythmia Arrhythmia P-value*
Died during hospitalization                                                                            
Did not die 98.2% 91.1% <0.001
Died 1.8% 8.9% <0.001
Length of stay (cleaned)                                                                                  
0 to 3 days 50.5% 36.7% <0.001
4 to 6 days 26.0% 27.4% <0.001
7 to 9 days 10.5% 14.1% <0.001
10 to 12 days 4.8% 7.3% <0.001
>13 days 8.3% 14.5% <0.001
Total charges (Mean) (USD) 47019.72 75925.28 <0.001
TABLE 4: Association between in-hospital outcomes and arrhythmia in epilepsy
patients.
*Significant P-values ≤ 0.05 at 95% confidence interval.
Mortality odds in epilepsy patients with arrhythmia
Table 4 shows the mortality odds associated with different variables in patients of epilepsy with
arrhythmia. Top five comorbidity predictors with higher odds of morality are: 1) metastatic
cancer (OR= 2.137, 95% CI= 1.983-2.304, p <0.001), 2) coagulopathy (OR= 1.888, 95% CI= 1.815-
1.964, p <0.001), 3) pulmonary circulation disorders (OR= 1.603, 95% CI= 1.511-1.700, p
<0.001), 4) solid tumor without metastasis (OR= 1.551, 95% CI= 1.432-1.681, p <0.001) and 5)
weight loss (OR= 1.344, 95% CI= 1.286-1.405, p <0.001). Associations with other variables are
shown in Table 5.
Variables Odds Ratio 95% CI P-value*
Age in years at admission
<18 Referent Referent  
18-44 1.219 1.107-1.343 <0.001
45-64 1.606 1.464-1.762 <0.001
65-84 1.685 1.536-1.848 <0.001
>85 1.798 1.631-1.982 <0.001
Elective Vs. Non-elective Admissions
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Non-elective 1.440 1.358-1.528 <0.001
Elective Referent Referent  
Indicator of Sex
Male Referent Referent  
Female 1.068 1.037-1.099 <0.001
Length of stay (cleaned)
1 to 3 days [1] 1.503 1.420-1.592 <0.001
4 to 6 days [2] 0.913 0.860 - 0.969 0.003
7 to 9 days Referent Referent  
10 to 12 days [4] 1.050 0.985-1.119 0.136
≥13 days [5] 1.067 1.003-1.135 0.003
Race
Caucasian Referent Referent  
Afro-American 0.929 0.894-0.966 <0.001
Hispanic 1.124 1.065-1.186 <0.001
Asian or Pacific Islander 1.567 1.425-1.723 <0.001
Native American 1.250 1.058-1.476 0.009
Other 1.477 1.367-1.595 <0.001
Co –morbidities#
RA/CVD .849 0.778-0.925 <0.001
Congestive Heart Failure 1.161 1.119-1.203 <0.001
Peripheral vascular disorders 1.091 1.039-1.145 <0.001
Hypertension .876 0.849 - 0.904 <0.001
Chronic pulmonary disease 0.960 0.929 – 0.993 <0.001
Pulmonary Circulation Disorders 1.603 1.511-1.700 <0.001
Paralysis 0.787 0.751-0.824 <0.001
Other neurological disorders 1.314 1.268-1.361 <0.001
Depression 0.572 0.546 - 0.600 <0.001
Deficiency anemia .801 0.774-0.828 <0.001
Coagulopathy 1.888 1.815 - 1.964 <0.001
Weight Loss 1.344 1.286- 1.405 <0.001
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Metastatic cancer 2.137 1.983-2.304 <0.001
Solid Tumor without Metastasis 1.551 1.432-1.681 <0.001
Diabetes, uncomplicated 1.170 1.130 - 1.211 <0.001
Hypothyroidism 0.702 0.673- 0.732 <0.001
Renal failure 1.437 1.387-1.789 <0.001
Fluid and Electrolyte Disorders 2.238 2.172-2.306 <0.001
Liver Disease 1.114 1.043-1.189 <0.001
TABLE 5: Multivariate predictors of mortality in epilepsy patients with arrhythmia.
*Significant P-value ≤ 0.05 at 95% confidence interval #Variables are Agency for Healthcare Research and Quality (AHRQ) co-
morbidity measures
Abbreviations: RA- rheumatoid arthritis, CVD- collagen vascular disease, CI - confidence interval.
Discussion
In this study, we tried to determine the different subtypes of arrhythmia in epilepsy. There was
an increased incidence observed in the age group of 65-84 years. Most cases were observed in
Caucasians. On the basis of comorbidities, the significant difference was seen in the presence
of cardiovascular, pulmonary, neurological, iron deficiency, renal dysfunction and diabetes
comorbid population. Fluid and electrolyte imbalance played a vital role in cardiac arrhythmia
in these patients. The most common subtype observed was atrial fibrillation. A scarce literature
is present about the subtypes of arrhythmia, but most of the authors agreed on the point that it
is a very common cause of sudden death in epilepsy. In our practice, crucial importance is given
to the management of the seizure episode during an emergency. Along with the treatment,
monitoring the patient for arrhythmia is also of significant importance [10-11].
The incidence of arrhythmia in epilepsy can be due to a causal association, shared risk factor
and resulting from epilepsy treatment itself. Most common of them is ictal asystole. Others
being postictal asystole, ictal bradycardia, ictal atrioventricular (AV) conduction block, postictal
AV-conduction block, postictal atrial flutter/atrial fibrillation and postictal ventricular
fibrillation [12-13]. The patients with chronic epilepsy or drug resistant epilepsy may present
with abnormalities of both sinoatrial (SA) and ventricular arrhythmia. These arrhythmias can
be detrimental, leading to SUDEP. There are many mechanisms proposed including activation or
inhibition of cortical autonomic centers, increase in vagal tone through activation of brainstem
reflex centers and respiratory failure. Although the exact pathophysiology is not known [14-15].
Growing up with epilepsy is socially stigmatized. As the age progresses, the comorbidities also
increase. The essential rationale for writing this manuscript is to increase an awareness among
physicians to improve the quality of life and prevent as many complications as we can.
According to American Epilepsy Society (AES), the most common cause of mortality associated
with this disease is SUDEP, excluding status epilepticus and other etiologies [16- 17]. The
SUDEP affects around 5000 patients only in the United States. The incidence is higher in
patients with generalized tonic clonic seizures (GTCS). It is also encouraged that the best way
to prevent SUDEP is treating GTCS [16, 18].
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The major mechanisms behind SUDEP are cardiac arrhythmias and asphyxia. In the case of
arrhythmia, the exact etiology is still unknown. Authors have suggested different theories like
inflammation by Interleukin-6 (IL-6), autonomic dysregulations or altered ion channel due to
drug resistant epilepsy [2, 4, 19]. The patients suffering from temporal lobe epilepsy are seen to
be at increased risk of post-ictal arrhythmia due to autonomic instability. Physicians and nurses
in the emergency department should be well trained for this dreadful complication in a patient
presenting with seizure episode [13, 20].
Limitations
This study carries few important limitations. First, all the patients with the diagnosis of
epilepsy were included in the study and further stratification in the context of various subtypes
of epilepsy could not be performed because of limitations of CCS coding. Likewise, the
substantial portion of arrhythmia subtypes must be included under the category of unspecified
causes due to coding limitations. Second, NIS database does not have the information about
electroencephalogram (EEG) parameters for the specific subtype of epilepsy and it could not be
found which type of epilepsy, whether generalized or localized, had the highest correlation
with arrhythmias. The NIS database contains a discharge-based data; same patients who might
have been admitted previously with different diagnosis might have been included again.
Nonetheless, this is the first study, which systematically analyzes burden of arrhythmias by
subtypes in the large sample of epilepsy population. Further research is suggested in this
direction, focusing on finding a relationship between epilepsy and arrhythmias, using
prospective randomized trials. 
Conclusions
In a nutshell, arrhythmias are frequent in 24.16% of population hospitalized with epilepsy with
atrial fibrillation being the most common subtype. Except for PSVT, all the other subtypes
showed significant prevalence among males. Mortality owing to arrhythmias in epilepsy
patients was higher. It also led to greater financial burden and utilization of other healthcare
resources.
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